Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary Expression Phenotypes Gene Literature (63) GO Terms (4) Nucleotides (53) Proteins (34) Interactants (60) Wiki
XB--991577

Papers associated with kcna3



???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? 1 2 ???pagination.result.next???

Sort Newest To Oldest Sort Oldest To Newest

Antinociceptive effects of new pyrazoles compounds mediated by the ASIC-1α channel, TRPV-1 and μMOR receptors., Florentino IF, Silva DPB, Cardoso CS, Menegatti R, de Carvalho FS, Lião LM, Pinto PM, Peigneur S, Costa EA, Tytgat J., Biomed Pharmacother. July 1, 2019; 115 108915.


C-Terminal residues in small potassium channel blockers OdK1 and OSK3 from scorpion venom fine-tune the selectivity., Kuzmenkov AI, Peigneur S, Chugunov AO, Tabakmakher VM, Efremov RG, Tytgat J, Grishin EV, Vassilevski AA., Biochim Biophys Acta Proteins Proteom. May 1, 2017; 1865 (5): 465-472.


Cortisone and hydrocortisone inhibit human Kv1.3 activity in a non-genomic manner., Yu J, Park MH, Choi SY, Jo SH., Naunyn Schmiedebergs Arch Pharmacol. June 1, 2015; 388 (6): 653-61.


Different solvent fractions of Acanthopanax senticosus harms exert antioxidant and anti-inflammatory activities and inhibit the human Kv1.3 channel., Jiang Y, Wang MH., J Med Food. April 1, 2015; 18 (4): 468-75.


Up-regulation of Kv1.3 channels by janus kinase 2., Hosseinzadeh Z, Warsi J, Elvira B, Almilaji A, Shumilina E, Lang F., J Membr Biol. April 1, 2015; 248 (2): 309-17.


Expression and function of a CP339,818-sensitive K⁺ current in a subpopulation of putative nociceptive neurons from adult mouse trigeminal ganglia., Sforna L, D'Adamo MC, Servettini I, Guglielmi L, Pessia M, Franciolini F, Catacuzzeno L., J Neurophysiol. April 1, 2015; 113 (7): 2653-65.


Up-Regulation of Voltage Gated K+ Channels Kv1.3 and Kv1.5 by Protein Kinase PKB/Akt., Warsi J, Fezai M, Fores M, Elvira B, Lang F., Cell Physiol Biochem. January 1, 2015; 37 (6): 2454-63.


Counteracting suppression of CFTR and voltage-gated K+ channels by a bacterial pathogenic factor with the natural product tannic acid., Ramu Y, Xu Y, Xu Y, Shin HG, Lu Z., Elife. October 14, 2014; 3 e03683.        


Down-regulation of K⁺ channels by human parvovirus B19 capsid protein VP1., Ahmed M, Almilaji A, Munoz C, Elvira B, Shumilina E, Bock CT, Kandolf R, Lang F., Biochem Biophys Res Commun. August 8, 2014; 450 (4): 1396-401.


Electrophysiological characterization of Ts6 and Ts7, K⁺ channel toxins isolated through an improved Tityus serrulatus venom purification procedure., Cerni FA, Pucca MB, Peigneur S, Cremonez CM, Bordon KC, Tytgat J, Arantes EC., Toxins (Basel). February 28, 2014; 6 (3): 892-913.              


Regulation of the voltage gated K channel Kv1.3 by recombinant human klotho protein., Almilaji A, Honisch S, Liu G, Elvira B, Ajay SS, Hosseinzadeh Z, Ahmed M, Munoz C, Sopjani M, Lang F., Kidney Blood Press Res. January 1, 2014; 39 (6): 609-22.


Tuning voltage-gated channel activity and cellular excitability with a sphingomyelinase., Combs DJ, Shin HG, Xu Y, Xu Y, Ramu Y, Lu Z., J Gen Physiol. October 1, 2013; 142 (4): 367-80.                    


Electrochemical strategy to scout 1,4-naphthoquinones effect on voltage gated potassium channels., Rodríguez-Fernández T, Ugalde-Saldívar VM, González I, Escobar LI, García-Valdés J., Bioelectrochemistry. August 1, 2012; 86 1-8.


Sigma-1 receptor alters the kinetics of Kv1.3 voltage gated potassium channels but not the sensitivity to receptor ligands., Kinoshita M, Matsuoka Y, Suzuki T, Mirrielees J, Yang J., Brain Res. May 3, 2012; 1452 1-9.


Effect of dextromethorphan on human K(v)1.3 channel activity: involvement of C-type inactivation., Lee JH, Lee JH, Choi SH, Shin TJ, Lee BH, Hwang SH, Kim HC, Nah SY., Eur J Pharmacol. January 25, 2011; 651 (1-3): 122-7.


A potent potassium channel blocker from Mesobuthus eupeus scorpion venom., Gao B, Peigneur S, Tytgat J, Zhu S., Biochimie. December 1, 2010; 92 (12): 1847-53.


Inhibition of voltage-gated K+ channels in dendritic cells by rapamycin., Tyan L, Sopjani M, Dërmaku-Sopjani M, Schmid E, Yang W, Thi Xuan N, Shumilina E, Lang F., Am J Physiol Cell Physiol. December 1, 2010; 299 (6): C1379-85.


A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library., Takacs Z, Toups M, Kollewe A, Johnson E, Cuello LG, Driessens G, Biancalana M, Koide A, Ponte CG, Perozo E, Gajewski TF, Suarez-Kurtz G, Koide S, Goldstein SA., Proc Natl Acad Sci U S A. December 29, 2009; 106 (52): 22211-6.


[Effects of telmisartan on voltage-gated Kv1.3 and Kv1.5 potassium channels expressed in Xenopus oocytes]., Li MW, Wang XP, Gao CY, Zou AR., Zhonghua Xin Xue Guan Bing Za Zhi. February 1, 2009; 37 (2): 165-8.


High extracellular potassium ion concentration attenuates the blockade action of ketanserin on Kv1.3 channels expressed in xenopus oocytes., Liang ZT, Wang XP, Zeng QT, Liao YH, Zou AR, Li L, Tu DN., Chin Med J (Engl). December 20, 2008; 121 (24): 2584-91.


A new Kaliotoxin selective towards Kv1.3 and Kv1.2 but not Kv1.1 channels expressed in oocytes., Abbas N, Belghazi M, Abdel-Mottaleb Y, Tytgat J, Bougis PE, Martin-Eauclaire MF., Biochem Biophys Res Commun. November 21, 2008; 376 (3): 525-30.


Hemitoxin, the first potassium channel toxin from the venom of the Iranian scorpion Hemiscorpius lepturus., Srairi-Abid N, Shahbazzadeh D, Chatti I, Mlayah-Bellalouna S, Mejdoub H, Borchani L, Benkhalifa R, Akbari A, El Ayeb M., FEBS J. September 1, 2008; 275 (18): 4641-50.


OdK2, a Kv1.3 channel-selective toxin from the venom of the Iranian scorpion Odonthobuthus doriae., Abdel-Mottaleb Y, Vandendriessche T, Clynen E, Landuyt B, Jalali A, Vatanpour H, Schoofs L, Tytgat J., Toxicon. June 15, 2008; 51 (8): 1424-30.


The molecular mechanism of toxin-induced conformational changes in a potassium channel: relation to C-type inactivation., Zachariae U, Schneider R, Velisetty P, Lange A, Seeliger D, Wacker SJ, Karimi-Nejad Y, Vriend G, Becker S, Pongs O, Baldus M, de Groot BL., Structure. May 1, 2008; 16 (5): 747-54.


Blockade action of ketanserin and increasing effect of potassium ion on Kv1.3 channels expressed in Xenopus oocytes., Wang X, Liao Y, Zou A, Li L, Tu D., Pharmacol Res. August 1, 2007; 56 (2): 148-54.


Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K+ channel in macrophages., Vicente R, Escalada A, Villalonga N, Texidó L, Roura-Ferrer M, Martín-Satué M, López-Iglesias C, Soler C, Solsona C, Tamkun MM, Felipe A., J Biol Chem. December 8, 2006; 281 (49): 37675-85.


Toxin-induced conformational changes in a potassium channel revealed by solid-state NMR., Lange A, Giller K, Hornig S, Martin-Eauclaire MF, Pongs O, Becker S, Baldus M., Nature. April 13, 2006; 440 (7086): 959-62.


A novel toxin from the venom of the scorpion Tityus trivittatus, is the first member of a new alpha-KTX subfamily., Abdel-Mottaleb Y, Coronas FV, de Roodt AR, Possani LD, Tytgat J., FEBS Lett. January 23, 2006; 580 (2): 592-6.


A truncated Kv1.1 protein in the brain of the megencephaly mouse: expression and interaction., Persson AS, Klement G, Almgren M, Sahlholm K, Nilsson J, Petersson S, Arhem P, Schalling M, Lavebratt C., BMC Neurosci. November 23, 2005; 6 65.          


Stichodactyla helianthus peptide, a pharmacological tool for studying Kv3.2 channels., Yan L, Herrington J, Goldberg E, Dulski PM, Bugianesi RM, Slaughter RS, Banerjee P, Brochu RM, Priest BT, Kaczorowski GJ, Rudy B, Garcia ML., Mol Pharmacol. May 1, 2005; 67 (5): 1513-21.


Regulation of the voltage gated K+ channel Kv1.3 by the ubiquitin ligase Nedd4-2 and the serum and glucocorticoid inducible kinase SGK1., Henke G, Maier G, Wallisch S, Boehmer C, Lang F., J Cell Physiol. May 1, 2004; 199 (2): 194-9.


KCNE4 is an inhibitory subunit to Kv1.1 and Kv1.3 potassium channels., Grunnet M, Rasmussen HB, Hay-Schmidt A, Rosenstierne M, Klaerke DA, Olesen SP, Jespersen T., Biophys J. September 1, 2003; 85 (3): 1525-37.


Synthesis and characterization of Pi4, a scorpion toxin from Pandinus imperator that acts on K+ channels., M'Barek S, Mosbah A, Sandoz G, Fajloun Z, Olamendi-Portugal T, Rochat H, Sampieri F, Guijarro JI, Mansuelle P, Delepierre M, De Waard M, Sabatier JM., Eur J Biochem. September 1, 2003; 270 (17): 3583-92.


Tityustoxin-K(alpha) blockade of the voltage-gated potassium channel Kv1.3., Rodrigues AR, Arantes EC, Monje F, Stühmer W, Varanda WA., Br J Pharmacol. July 1, 2003; 139 (6): 1180-6.


Dual-function vector for protein expression in both mammalian cells and Xenopus laevis oocytes., Jespersen T, Grunnet M, Angelo K, Klaerke DA, Olesen SP., Biotechniques. March 1, 2002; 32 (3): 536-8, 540.


Cerebral localization and regulation of the cell volume-sensitive serum- and glucocorticoid-dependent kinase SGK1., Wärntges S, Friedrich B, Henke G, Duranton C, Lang PA, Waldegger S, Meyermann R, Kuhl D, Speckmann EJ, Obermüller N, Witzgall R, Mack AF, Wagner HJ, Wagner A, Bröer S, Lang F., Pflugers Arch. February 1, 2002; 443 (4): 617-24.


Pegylation: a method for assessing topological accessibilities in Kv1.3., Lu J, Deutsch C., Biochemistry. November 6, 2001; 40 (44): 13288-301.


Dynamic interaction of S5 and S6 during voltage-controlled gating in a potassium channel., Espinosa F, Fleischhauer R, McMahon A, Joho RH., J Gen Physiol. August 1, 2001; 118 (2): 157-70.                  


Cloning and expression of three K+ channel cDNAs from Xenopus muscle., Fry M, Paterno G, Moody-Corbett F., Brain Res Mol Brain Res. June 20, 2001; 90 (2): 135-48.          


Gallamine triethiodide selectively blocks voltage-gated potassium channels in Ranvier nodes., Hinck D, Wulff H, Koppenhöfer E., Gen Physiol Biophys. March 1, 2001; 20 (1): 83-95.


Chemical synthesis and characterization of Pi1, a scorpion toxin from Pandinus imperator active on K+ channels., Fajloun Z, Carlier E, Lecomte C, Geib S, Di Luccio E, Bichet D, Mabrouk K, Rochat H, De Waard M, Sabatier JM., Eur J Biochem. August 1, 2000; 267 (16): 5149-55.


Close association of the N terminus of Kv1.3 with the pore region., Yao X, Liu W, Tian S, Rafi H, Segal AS, Desir GV., J Biol Chem. April 14, 2000; 275 (15): 10859-63.


Transmembrane biogenesis of Kv1.3., Tu L, Wang J, Helm A, Skach WR, Deutsch C., Biochemistry. February 1, 2000; 39 (4): 824-36.


Regulation of Shaker-type potassium channels by hypoxia. Oxygen-sensitive K+ channels in PC12 cells., Conforti L, Millhorn DE., Adv Exp Med Biol. January 1, 2000; 475 265-74.


Mapping the functional anatomy of BgK on Kv1.1, Kv1.2, and Kv1.3. Clues to design analogs with enhanced selectivity., Alessandri-Haber N, Lecoq A, Gasparini S, Grangier-Macmath G, Jacquet G, Harvey AL, de Medeiros C, Rowan EG, Gola M, Ménez A, Crest M., J Biol Chem. December 10, 1999; 274 (50): 35653-61.


Distribution in rat brain of binding sites of kaliotoxin, a blocker of Kv1.1 and Kv1.3 alpha-subunits., Mourre C, Chernova MN, Martin-Eauclaire MF, Bessone R, Jacquet G, Gola M, Alper SL, Crest M., J Pharmacol Exp Ther. December 1, 1999; 291 (3): 943-52.


Role of disulfide bonds in the structure and potassium channel blocking activity of ShK toxin., Pennington MW, Lanigan MD, Kalman K, Mahnir VM, Rauer H, McVaugh CT, Behm D, Donaldson D, Chandy KG, Kem WR, Norton RS., Biochemistry. November 2, 1999; 38 (44): 14549-58.


The effects of Shaker beta-subunits on the human lymphocyte K+ channel Kv1.3., McCormack T, McCormack K, Nadal MS, Vieira E, Ozaita A, Rudy B., J Biol Chem. July 16, 1999; 274 (29): 20123-6.


Characterization of a regulatory region in the N-terminus of rabbit kv1.3., Yao X, Huang Y, Kwan HY, Chan P, Segal AS, Desir G., Biochem Biophys Res Commun. August 19, 1998; 249 (2): 492-8.


Evidence for interaction between transmembrane segments in assembly of Kv1.3., Sheng Z, Skach W, Santarelli V, Deutsch C., Biochemistry. December 9, 1997; 36 (49): 15501-13.

???pagination.result.page??? 1 2 ???pagination.result.next???